Rekah Pharmaceutical Industry Ltd Net Asset Quality Index
Rekah Pharmaceutical Industry Ltd net asset quality index. Rekah Pharmaceutical Industry Ltd (REKA) has a Net Asset Quality Index of 33.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA421.48 Million minus total liabilities of ILA281.29 Million yields net assets of ILA140.18 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Rekah Pharmaceutical Industry Ltd for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Rekah Pharmaceutical Industry Ltd (2004–2025)
Net asset quality index of Rekah Pharmaceutical Industry Ltd from 2004 to 2025. This chart shows how Rekah Pharmaceutical Industry Ltd's Net Asset Quality Index has evolved across 22 annual periods from 2004 to 2025. As of June 2026, the index stands at 33.3%, representing net assets of ILA140.18 Million against total assets of ILA421.48 Million ILA. Check REKA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Rekah Pharmaceutical Industry Ltd Net Asset Quality Index by Year (2004–2025)
Rekah Pharmaceutical Industry Ltd net asset quality index by year from 2004 to 2025. The table below presents the year-by-year Net Asset Quality Index for Rekah Pharmaceutical Industry Ltd from 2004 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see REKA market cap overview.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.0% | ILA144.21 Million | ILA423.68 Million | ILA279.47 Million | ▼ -2.2 pp |
| 2024 | 36.2% | ILA161.98 Million | ILA447.22 Million | ILA285.24 Million | ▲ +4.1 pp |
| 2023 | 32.1% | ILA155.59 Million | ILA484.72 Million | ILA329.14 Million | ▼ -4.0 pp |
| 2022 | 36.1% | ILA162.08 Million | ILA448.42 Million | ILA286.34 Million | ▼ -3.4 pp |
| 2021 | 39.6% | ILA173.06 Million | ILA437.09 Million | ILA264.02 Million | ▲ +0.1 pp |
| 2020 | 39.5% | ILA165.59 Million | ILA419.69 Million | ILA254.10 Million | ▼ -2.8 pp |
| 2019 | 42.3% | ILA155.22 Million | ILA367.11 Million | ILA211.89 Million | ▼ -7.9 pp |
| 2018 | 50.2% | ILA150.66 Million | ILA300.28 Million | ILA149.62 Million | ▲ +1.1 pp |
| 2017 | 49.0% | ILA144.62 Million | ILA294.95 Million | ILA150.33 Million | ▲ +16.2 pp |
| 2016 | 32.8% | ILA105.86 Million | ILA322.72 Million | ILA216.86 Million | ▼ -5.4 pp |
| 2015 | 38.2% | ILA123.66 Million | ILA323.82 Million | ILA200.17 Million | ▲ +13.3 pp |
| 2014 | 24.8% | ILA77.06 Million | ILA310.11 Million | ILA233.05 Million | ▼ -1.4 pp |
| 2013 | 26.2% | ILA79.51 Million | ILA303.16 Million | ILA223.65 Million | ▲ +2.4 pp |
| 2012 | 23.9% | ILA71.17 Million | ILA298.07 Million | ILA226.90 Million | ▲ +1.6 pp |
| 2011 | 22.3% | ILA64.00 Million | ILA286.99 Million | ILA222.98 Million | ▲ +0.2 pp |
| 2010 | 22.1% | ILA63.78 Million | ILA287.97 Million | ILA224.18 Million | ▼ -0.9 pp |
| 2009 | 23.0% | ILA64.15 Million | ILA278.40 Million | ILA214.25 Million | ▲ +2.9 pp |
| 2008 | 20.2% | ILA58.62 Million | ILA290.50 Million | ILA231.87 Million | ▼ -2.1 pp |
| 2007 | 22.3% | ILA67.10 Million | ILA300.96 Million | ILA233.86 Million | ▲ +1.5 pp |
| 2006 | 20.8% | ILA61.54 Million | ILA296.53 Million | ILA234.99 Million | ▼ -1.3 pp |
| 2005 | 22.0% | ILA58.85 Million | ILA267.00 Million | ILA208.15 Million | ▼ -2.1 pp |
| 2004 | 24.2% | ILA48.86 Million | ILA202.04 Million | ILA153.18 Million | — |